International Biotechnology Trust as of June 30, 2019
Portfolio Holdings for International Biotechnology Trust
International Biotechnology Trust holds 64 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gilead Sciences (GILD) | 7.9 | $21M | 316k | 67.55 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 5.8 | $16M | 85k | 183.31 | |
| Neurocrine Biosciences (NBIX) | 4.9 | $13M | 157k | 84.43 | |
| Celgene Corporation | 4.9 | $13M | 143k | 92.43 | |
| Alexion Pharmaceuticals | 4.8 | $13M | 99k | 130.98 | |
| Amgen (AMGN) | 4.5 | $12M | 66k | 184.23 | |
| Ptc Therapeutics I (PTCT) | 4.3 | $12M | 259k | 44.95 | |
| D Stemline Therapeutics | 4.2 | $11M | 744k | 15.32 | |
| Biogen Idec (BIIB) | 3.7 | $10M | 43k | 233.84 | |
| Exelixis (EXEL) | 3.5 | $9.5M | 444k | 21.38 | |
| Illumina (ILMN) | 3.4 | $9.2M | 25k | 368.17 | |
| Insmed (INSM) | 3.4 | $9.1M | 357k | 25.55 | |
| Halozyme Therapeutics (HALO) | 3.0 | $8.2M | 476k | 17.16 | |
| Regeneron Pharmaceuticals (REGN) | 2.7 | $7.3M | 23k | 312.86 | |
| Incyte Corporation (INCY) | 2.5 | $6.7M | 79k | 84.95 | |
| Sage Therapeutics (SAGE) | 2.3 | $6.2M | 34k | 183.08 | |
| BioMarin Pharmaceutical (BMRN) | 2.0 | $5.5M | 64k | 85.65 | |
| Ionis Pharmaceuticals (IONS) | 2.0 | $5.3M | 83k | 64.27 | |
| G1 Therapeutics (GTHX) | 1.7 | $4.5M | 146k | 30.63 | |
| Seattle Genetics | 1.6 | $4.2M | 61k | 69.21 | |
| Kalvista Pharmaceuticals (KALV) | 1.5 | $4.2M | 188k | 22.20 | |
| Sarepta Therapeutics (SRPT) | 1.5 | $4.0M | 26k | 151.92 | |
| Horizon Therapeutics Pub SHS | 1.1 | $3.1M | 128k | 24.05 | |
| Abiomed | 1.1 | $3.0M | 12k | 260.43 | |
| Ascendis Pharma AS Sponsored ADR (ASND) | 1.1 | $3.0M | 26k | 115.08 | |
| Amarin Corp Sponsored ADR (AMRN) | 1.0 | $2.7M | 137k | 19.38 | |
| ArQule | 1.0 | $2.6M | 239k | 11.00 | |
| Iovance Biotherapeutics (IOVA) | 0.9 | $2.5M | 104k | 24.45 | |
| Alnylam Pharmaceuticals (ALNY) | 0.9 | $2.5M | 34k | 72.57 | |
| Biohaven Pharmaceutical Holding | 0.8 | $2.2M | 51k | 43.79 | |
| Intersect Ent | 0.8 | $2.2M | 96k | 22.72 | |
| Bluebird Bio (BLUE) | 0.8 | $2.2M | 17k | 127.24 | |
| Uniqure Nv SHS (QURE) | 0.8 | $2.1M | 28k | 78.07 | |
| Nektar Therapeutics (NKTR) | 0.8 | $2.1M | 60k | 35.58 | |
| Repligen Corporation (RGEN) | 0.8 | $2.1M | 24k | 85.88 | |
| Millendo Therapeutics | 0.8 | $2.1M | 178k | 11.56 | |
| GW Pharmaceuticals Ads | 0.7 | $1.9M | 11k | 172.45 | |
| Agios Pharmaceuticals (AGIO) | 0.7 | $1.8M | 37k | 49.89 | |
| Sutro Biopharma (STRO) | 0.6 | $1.6M | 145k | 11.31 | |
| Sangamo Biosciences (SGMO) | 0.6 | $1.6M | 150k | 10.77 | |
| Blueprint Medicines (BPMC) | 0.6 | $1.6M | 17k | 94.35 | |
| Alkermes SHS (ALKS) | 0.6 | $1.6M | 70k | 22.60 | |
| Myokardia | 0.6 | $1.5M | 30k | 50.17 | |
| Global Blood Therapeutics In | 0.5 | $1.5M | 28k | 52.57 | |
| ACADIA Pharmaceuticals (ACAD) | 0.5 | $1.4M | 53k | 26.70 | |
| EXACT Sciences Corporation (EXAS) | 0.5 | $1.3M | 11k | 118.04 | |
| Acceleron Pharma | 0.5 | $1.2M | 30k | 41.10 | |
| Mirati Therapeutics | 0.4 | $1.1M | 11k | 103.03 | |
| Myriad Genetics (MYGN) | 0.4 | $1.1M | 40k | 27.77 | |
| Globus Med Inc cl a (GMED) | 0.4 | $1.0M | 24k | 42.31 | |
| Momenta Pharmaceuticals | 0.4 | $997k | 80k | 12.46 | |
| Arena Pharmaceuticals | 0.4 | $967k | 17k | 58.61 | |
| Fibrogen (FGEN) | 0.3 | $889k | 20k | 45.13 | |
| Concert Pharmaceuticals I equity | 0.3 | $839k | 70k | 11.99 | |
| Ligand Pharmaceuticals In (LGND) | 0.3 | $833k | 7.3k | 114.11 | |
| Tricida | 0.3 | $788k | 20k | 39.40 | |
| Akcea Therapeutics Inc equities | 0.3 | $743k | 32k | 23.42 | |
| Amicus Therapeutics (FOLD) | 0.3 | $730k | 59k | 12.46 | |
| Zogenix | 0.3 | $687k | 14k | 47.71 | |
| Supernus Pharmaceuticals (SUPN) | 0.2 | $659k | 20k | 33.03 | |
| PROQR therapeutics N V Shs Euro (PRQR) | 0.2 | $511k | 56k | 9.12 | |
| Radius Health | 0.2 | $414k | 17k | 24.35 | |
| Retrophin | 0.1 | $362k | 18k | 20.11 | |
| Dermira | 0.1 | $287k | 30k | 9.57 |
